Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)
South Korea · Delayed Price · Currency is KRW 5,950.00
+130.00 (2.23%)
At close: Aug 24, 2026
Sinil Pharmaceutical Market Cap
Sinil Pharmaceutical has a market cap or net worth of 66.21 billion as of August 21, 2026. Its market cap has decreased by -7.91% in one year.
Market Cap
66.21B
Enterprise Value
28.16B
Revenue
82.18B
Ranking
n/a
PE Ratio
9.68
Stock Price
5,950.00
ChartMarket Cap Chart
Since November 20, 2000, Sinil Pharmaceutical's market cap has increased from 16.83B to 66.21B, an increase of 293.47%. That is a compound annual growth rate of 5.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 66.21B | -4.12% |
| Dec 30, 2025 | 69.05B | -5.60% |
| Dec 30, 2024 | 73.15B | -16.60% |
| Dec 28, 2023 | 87.71B | -9.43% |
| Dec 29, 2022 | 96.84B | -24.53% |
| Dec 30, 2021 | 128.31B | -48.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 85.75B |
| Sam-A Pharm. | 83.55B |
| KOREA PHARMA | 82.24B |
| Daehan Nupharm | 78.32B |
| Polaris AI Pharma | 69.07B |
| Optipharm.CO.,LTD | 66.97B |
| Hwail Pharmaceutical | 66.84B |
| Sinsin Pharmaceutical | 66.30B |